102 related articles for article (PubMed ID: 8107282)
1. [Blood coagulation and fibrinolysis in ischemic heart disease].
Sakamoto T; Ogawa H; Miyao Y; Yasue H
Rinsho Byori; 1994 Jan; 42(1):39-44. PubMed ID: 8107282
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology of acute coronary syndromes].
Ogawa H
J Cardiol; 1999 Mar; 33 Suppl 1():9-16. PubMed ID: 10342131
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of single fibrinopeptide A determination in patients with acute ischemic coronary artery syndromes.
Alemán-Gómez JA; López-Candalez A; Freytes CO; Mignucci M; Linares E
Bol Asoc Med P R; 1992; 84(4-5):134-8. PubMed ID: 1295502
[TBL] [Abstract][Full Text] [Related]
4. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
[TBL] [Abstract][Full Text] [Related]
6. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
7. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
9. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
[TBL] [Abstract][Full Text] [Related]
10. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
[TBL] [Abstract][Full Text] [Related]
11. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
12. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
[TBL] [Abstract][Full Text] [Related]
14. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
[TBL] [Abstract][Full Text] [Related]
15. Subclinical activation of fibrinolysis in atherosclerotic disease detected by B beta 15-42 assay.
Marongiu F; Mamusa AM; Mameli G; Conti M; Sorano GG; Biondi G; Farci P; Balestrieri A
Ric Clin Lab; 1989; 19(2):157-63. PubMed ID: 2528202
[TBL] [Abstract][Full Text] [Related]
16. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.
Merlini PA; Bauer KA; Oltrona L; Ardissino D; Cattaneo M; Belli C; Mannucci PM; Rosenberg RD
Circulation; 1994 Jul; 90(1):61-8. PubMed ID: 8026047
[TBL] [Abstract][Full Text] [Related]
17. Fibrinopeptide A is released into the coronary circulation after coronary spasm.
Oshima S; Yasue H; Ogawa H; Okumura K; Matsuyama K
Circulation; 1990 Dec; 82(6):2222-5. PubMed ID: 2146992
[TBL] [Abstract][Full Text] [Related]
18. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
Douglas JT; Lowe GD; Forbes CD; Prentice CR
Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
[TBL] [Abstract][Full Text] [Related]
19. [Clinical presentation of unstable angina may influence the formation of thrombin during spontaneous episodes of ischemia].
Meo A; Quaranta G; Liuzzo G; Cuculo A; Summaria F; van de Greef W; Kluft C; Biasucci LM; Maseri A
Cardiologia; 1998 May; 43(5):493-7. PubMed ID: 9701880
[TBL] [Abstract][Full Text] [Related]
20. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.
Masuda T; Yasue H; Ogawa H; Misumi I; Sakamoto T; Okubo H; Miyao Y; Kato H
Am Heart J; 1992 Aug; 124(2):314-9. PubMed ID: 1636575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
